Alkeus Pharmaceuticals

Alkeus

The company develops oral therapies to treat serious retinal conditions, including Stargardt disease and geographic atrophy, for patients at risk of vision loss.

Iveric Bio

This biopharmaceutical company develops therapeutic treatments for retinal diseases and provides these medicines to patients with age-related macular degeneration and inherited conditions.

Atsena Therapeutics

This clinical-stage company develops gene therapies to treat and prevent inherited retinal diseases for patients with conditions such as X-linked retinoschisis and Stargardt disease.

Breye Therapeutics

This biopharmaceutical company develops orally administered medicines for patients with retinal vascular diseases such as diabetic retinopathy and age-related macular degeneration.

ONL Therapeutics

This biopharmaceutical company develops neuroprotective peptide therapies to prevent retinal cell death and preserve vision for patients with retinal diseases and conditions.

Bikam Pharmaceuticals

This drug discovery company develops small-molecule therapies for patients with ophthalmic diseases such as retinitis pigmentosa.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Atsena

This clinical-stage gene therapy company develops genetic medicines to reverse or prevent blindness for patients with inherited retinal diseases.